These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38659869)

  • 1. Differential Behavior of Conformational Dynamics in Active and Inactive States of Cannabinoid Receptor 1.
    Isu UH; Polasa A; Moradi M
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism.
    Gavryushov S; Bashilov A; Cherashev-Tumanov KV; Kuzmich NN; Burykina TI; Izotov BN
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation.
    Ji S; Yang W; Yu W
    Sci Rep; 2021 Nov; 11(1):22369. PubMed ID: 34785728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel in the Activation Mechanism of the Type I Cannabinoid Receptor.
    Sarkar A; Mitra A; Borics A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation.
    Díaz Ó; Dalton JAR; Giraldo J
    J Med Chem; 2019 Jun; 62(11):5638-5654. PubMed ID: 31095906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch.
    Singh R; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Guarnieri F
    J Pept Res; 2002 Dec; 60(6):357-70. PubMed ID: 12464114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations.
    Loo JSE; Emtage AL; Murali L; Lee SS; Kueh ALW; Alexander SPH
    RSC Adv; 2019 May; 9(28):15949-15956. PubMed ID: 35521393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional residues essential for the activation of the CB1 cannabinoid receptor.
    Shim JY; Padgett L
    Methods Enzymol; 2013; 520():337-55. PubMed ID: 23332708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MD Simulations Revealing Special Activation Mechanism of Cannabinoid Receptor 1.
    Wu Y; Li X; Hua T; Liu ZJ; Liu H; Zhao S
    Front Mol Biosci; 2022; 9():860035. PubMed ID: 35425811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
    Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
    Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.
    Ahn KH; Scott CE; Abrol R; Goddard WA; Kendall DA
    Proteins; 2013 Aug; 81(8):1304-17. PubMed ID: 23408552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.
    Hu J; Feng Z; Ma S; Zhang Y; Tong Q; Alqarni MH; Gou X; Xie XQ
    J Chem Inf Model; 2016 Jun; 56(6):1152-63. PubMed ID: 27186994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
    Fay JF; Farrens DL
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the interaction of SR141716A with the CB1 receptor.
    Shim JY; Bertalovitz AC; Kendall DA
    J Biol Chem; 2012 Nov; 287(46):38741-54. PubMed ID: 22995906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the conformational transitions of LIMK2 active and inactive states to ponder specific druggable states through microsecond scale molecular dynamics simulation.
    Nagarajan H; Samdani A; Umashankar V; Jeyakanthan J
    J Comput Aided Mol Des; 2022 Jun; 36(6):459-482. PubMed ID: 35652973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
    Niesen MJ; Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists.
    Gullapalli S; Amrutkar D; Gupta S; Kandadi MR; Kumar H; Gandhi M; Karande V; Narayanan S
    Neuropharmacology; 2010 Jun; 58(8):1215-9. PubMed ID: 20214912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
    Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
    J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics Simulations for the Determination of the Characteristic Structural Differences between Inactive and Active States of Wild Type and Mutants of the Orexin2 Receptor.
    Yokoi S; Mitsutake A
    J Phys Chem B; 2021 May; 125(17):4286-4298. PubMed ID: 33885321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.